IGC PHARMA INC (IGC) Stock News

IGC Pharma: Fiscal Year 2025 Financial and Operational Highlights - A Year of Transformative Progress in Alzheimer's Innovation

US Stocks Likely To Open Higher, Continuing Record-Setting Advances: June Has Never Seen An All-Time High Since 1950, Highlights Expert

U.S. futures rose on Monday after a record close on Friday. Futures of major benchmark indices were trading higher.

Mentions: SPY PRGS BA QQQ ...

Progress Software, Exicure And 3 Stocks To Watch Heading Into Monday

U.S. stock futures up, focus on PRGS, XCUR, QMCO earnings. VERO jumps 43.6% after stake increase, IGC reports positive results. Check out Cramer's oil pick. Photo: Shutterstock.

Mentions: PRGS XCUR QMCO VERO

IGC Pharma to Host Fiscal Year-End 2025 Shareholder Update Call on Monday June 30, 2025

IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer's Innovation and AI-Driven Programs

IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep Disturbances

IGC Pharma Expands Holiby(TM) Product Line With 'Longevity' and 'Renew' - Targeting the Multi-Billion-Dollar Anti-Aging Market

IGC Pharma Expands CALMA Trial to Oklahoma, Partnering with Dr. David McCoy at Tekton Research in Yukon

Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates

Plus (PSTV) delivered earnings and revenue surprises of -229.41% and 42.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: PSTV

IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer's Market

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting

IGC Pharma Reports Third Quarter Fiscal 2025 Results

IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of Holiby(TM)

IGC Pharma Welcomes Strategic Investment from Advisors

Expedia Group, Inc. (EXPE): Among the Best Cruise Stocks to Buy According to Hedge Funds

We recently published a list of 12 Best Cruise Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Expedia Group, Inc. (NASDAQ:EXPE) stands against other best cruise stocks to buy according to hedge funds. Overview of the Cruise Line Industry The cruise industry is on […]

Mentions: EXPE JPM HAS CALM ...

Hasbro, Inc. (HAS): A Bull Case Theory

We came across a bullish thesis on Hasbro, Inc. (HAS) on Substack by The Reservist. In this article, we will summarize the bulls’ thesis on HAS. Hasbro, Inc. (HAS)’s share was trading at $50.71 as of April 8th. HAS’s trailing and forward P/E were 18.44 and 11.99 respectively according to Yahoo Finance. Hasbro represents a compelling investment […]

Mentions: HAS VZ DIS EXPE ...

IGC Pharma Expands CALMA Alzheimer's Phase 2 Trial with Prestigious Research Site at Butler Hospital's Memory and Aging Program

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health Sciences

IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in Florida

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q3 results. We believe more positive clinical data in 2025 to be strong catalysts for stock. Raising P/T to $4.25"

IGC Pharma Announces Equity Analyst Update by Alliance Global Partners (AGP) about the “Progressing Alzheimer-targeting efforts with notable Phase 2 CALMA interim results”

IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer's and Dementia Detection

IGC Pharma Named Top 15 Finalist in NIA PREPARE Challenge for AI-Driven Early Detection of Alzheimer's Disease

IGC Pharma Appoints Former Virginia Governor Terry McAuliffe as Strategic Advisor

IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment